For cash-pay programs
GLP-1 · Peptides · Hormones
The prescription is only as safe as the history behind it.
The programs that last will be the ones that can prove they knew the patient before they wrote the script.
The gap, one patient
Every answer was no. The record said otherwise.
Meet Dana: 5'6", 190 pounds, eligible on paper. She fills out a standard intake honestly, or thinks she does. Tap each answer to see what her own medical records show.
Illustrative patient. Not a real record. Label references: Wegovy prescribing information.
None of this is rare or hidden. It was already written down, in records that exist today, spread across a doctor's office, a hospital, a lab and two pharmacies. It just was not in front of the prescriber.
Not a hypothetical
Dana is illustrative. This patient was not.
A woman asked an online program for a GLP-1. Her intake said no medical history and no medications. When her records came back, they showed seven active prescriptions and stage 3 kidney disease.
A nurse on our clinical team called her back personally, walked her through what her own chart said, and urged her to talk to her doctor before starting anything.
It is happening every day in GLP-1 and peptide programs.
A real case from our own work. Identifying details withheld.
The moment
Speed won the first chapter. Proof wins the next one.
11%
of U.S. adults now take a GLP-1 for weight loss, up from 3% in 2024.
Gallup, 2026
91.8%
of online sellers prescribed to a researcher posing as a patient. 45 of 49 sites.
JAMA secret-shopper study, Jul 2026
≤1 day
median time from intake to prescription.
JAMA, Jul 2026
26.5%
of the 49 sites required a video visit. Most prescribed with no clinician conversation.
JAMA, Jul 2026
The bar is moving for everyone. Medical boards already say prescribing “based solely on static online questionnaires” is not acceptable. Regulators and plaintiffs are now pointing at the same gap.
The answer
One verified history. Built from the records, not recall.
Retrieve.
With the patient's written authorization, we request records from physicians, hospitals, labs and pharmacies.
Prove.
Every record is scored for trust. Where did it come from? How complete and recent is it? Do the sources agree? Only the records that need a closer look go to clinical review.
Deliver.
The history reaches your prescriber by API or secure folder, configured to the questions your intake already asks. Documented facts only. Every finding carries its source.
We don't decide the care. We make sure everyone who does can trust what they're looking at. And we are honest about what we don't know: an undocumented condition is not a negative finding.
What it is worth
The companies that win will not prescribe fastest. They will practice medicine.
Safety
The contraindication surfaces before the first dose.
A family cancer history, a past pancreatitis, a drug that interacts: found in the record and in front of the prescriber before the script. Not in the ER three weeks later.
Defensibility
A record of what you knew, and when.
When a complaint, a claim or a regulator asks how a decision was made, the answer is documented, sourced and scored. Not a checkbox the patient ticked.
Your clinicians
Protect the licenses behind every script.
Every prescription puts a clinician's license on the line. Documented history is the best protection you can hand the people you depend on.
Meet us in person
Eudēmonia Summit
West Palm Beach · Nov 5 to 8
SuperTruth session · Thursday, Nov 5 · Coral ABC
Next step
Run your own intake against the record. 15 minutes.
Tell us what you prescribe. We will send the one-page briefing and a link to pick a time at the summit or after.
Everyone is compiling records. Almost nobody is proving them.
Data truth is AI truth. A model or agent is only as true as the records it acts on.
Sources: Gallup, “GLP-1 Usage Reaches New High,” 2026. JAMA secret-shopper study of 49 online GLP-1 sellers, Jul 2026. Wegovy prescribing information, FDA. Federation of State Medical Boards, model policy on the appropriate use of telemedicine, Apr 2022. Figures drawn from public sources as of September 2026. The patient named Dana is illustrative and is not a real record. This page is informational only and is not medical, legal or billing advice. Prescribing decisions remain with the treating clinician.